Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571 [5]

Haematologica

Volumn 86, Issue 9, 2001, Pages 993-994

  Baron, F ^a   Frere, P ^a   Fillet, G ^a   Beguin, Y ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

DLI; HSCT; Ph chromosome positive acute leukemia; STI 571

Indexed keywords

IMATINIB; STEROID; TACROLIMUS;

ACUTE LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; LYMPHOCYTE TRANSFUSION; RECURRENT CANCER; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; LYMPHOCYTE TRANSFUSION; PIPERAZINES; PYRIMIDINES; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0034797322     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation
2. Adoptive immunotherapy insights from donor lymphocyte infusions
3. Infusion of donor lymphocytes to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease
4. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
5. Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia
6. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation
7. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
8. Chronic myeloid leukaemia: Transplantation issues